Nu-Med Plus Inc.

Nu-Med Plus Inc.

OOTC:NUMD
0.01
USD
+0.00
(+11.76%)
0.00EPS
967,157.08Market Cap

Total Valuation

USD

As of June 30, 2026, Nu-Med Plus Inc. carries a market capitalization of 967,157.08, placing it among publicly traded companies globally. Its enterprise value stands at 1.18M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap967,157.08
Enterprise Value1.18M

Share Statistics

As of June 30, 2026, Nu-Med Plus Inc. has 83.55M shares outstanding.

Shares Outstanding83.55M

Valuation Ratios

These figures are as of June 30, 2026.

PB Ratio-3.62
P/TBV Ratio-3.62
P/FCF Ratio-18.70
P/OCF Ratio-18.70

Financial Position

As of June 30, 2026, Nu-Med Plus Inc. maintains a current ratio of 0.05, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -83.18, indicating conservative leverage, while an interest coverage ratio of -5.42 demonstrates limited ability to service its debt obligations.

Current Ratio0.05
Quick Ratio0.02
Debt / Equity-83.18
Debt / EBITDA-4.01
Interest Coverage-5.42

Financial Efficiency

These figures cover the twelve months ended June 30, 2026. Return on assets (ROA) is negative at -197.34, reflecting losses generated across the asset base. The company generates approximately - - in revenue per employee across its workforce of 2.00, a quick read on workforce productivity versus industry peers.

Return on Assets (ROA)-197.34
Employee Count2.00

Stock Price Statistics

USD

As of the close on November 13, 2026, Nu-Med Plus Inc.'s stock has declined approximately 62.00% over the past 52 weeks. The 50-day moving average sits at 0.01, while the 200-day moving average is 0.03.

52-Week Price Change-62.00%
50-Day Moving Average0.01
200-Day Moving Average0.03

Income Statement

USD

Over the twelve months ended June 30, 2026, Nu-Med Plus Inc. generated - - in revenue and converted that into -20,792.00 in net income, yielding earnings per share of 0.00. EBITDA reached -55,543.00, while operating income came in at -55,543.00.

Operating Income-55,543.00
Pretax Income-20,792.00
Net Income-20,792.00
EBITDA-55,543.00
EBIT-55,543.00

Balance Sheet

USD

As of June 30, 2026, Nu-Med Plus Inc. holds 5,409.00 in cash and equivalents against 222,500.00 in total debt, resulting in a net debt position of 217,091.00. Total book value stands at -267,486.00, with working capital of -267,486.00 providing operational flexibility.

Cash & Cash Equivalents5,409.00
Total Debt222,500.00
Net Debt217,091.00
Equity (Book Value)-267,486.00
Working Capital-267,486.00

Cash Flow

USD

Nu-Med Plus Inc. produced -51,721.00 in operating cash flow over the twelve months ended June 30, 2026.

Operating Cash Flow-51,721.00
Free Cash Flow-51,721.00

Dividends & Yields

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -5.35: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -5.82, meaning Nu-Med Plus Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Shareholder Yield-5.82
FCF Yield-5.35

Scores

As of June 30, 2026, Nu-Med Plus Inc. has an Altman Z-Score of -1,115.62, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-1,115.62